Brief: Innoviva Submits Non-Binding Proposal To Acquire Of Entasis Therapeutics
Feb 2 (Reuters) - Entasis Therapeutics Holdings Inc
ETTX.O :
* INNOVIVA - ON FEB 1, 2022, SUBMITTED NON-BINDING PROPOSAL
TO
ACQUIRE ALL OF OUTSTANDING STOCK OF ENTASIS THERAPEUTICS
HOLDINGS NOT OWNED BY INNOVIVA
* INNOVIVA SAYS SUBMITS PROPOSAL TO BUY ALL OF ENTASIS
THERAPEUTICS' OUTSTANDING SHARES OF COMMON STOCK AT $1.80 PER
SHARE FOR CASH
Source text for Eikon: ID:
Further company coverage: ETTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innoviva
See all newsInnoviva, Inc. reports results for the quarter ended June 30 - Earnings Summary
Innoviva Q2 revenue rises on higher net product sales
Brief: Innoviva Q2 Royalty Revenue USD 56.334 Million
Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
Brief: Innoviva Q1 Royalty Revenue USD 55.167 Million